Clinical Trial Update: A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine

View source ↗

Summary

A completed clinical trial comparing recombinant human brain natriuretic peptide to dobutamine in patients with acute decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)
• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Nantong University | Conditions: Acute Decompensated Heart Failure | Status: COMPLETED